Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Why so many significant phase III results in clinical trials?

View ORCID ProfileJérôme Adda, Christian Decker, View ORCID ProfileMarco Ottaviani
doi: https://doi.org/10.1101/19001495
Jérôme Adda
†Department of Economics and IGIER, Bocconi University, Via Roberto Sarfatti 25, 20136 Milan, Italy. Phone: +39–02–5836–5572. E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jérôme Adda
  • For correspondence: jerome.adda{at}unibocconi.it
Christian Decker
‡Department of Economics, University of Zurich, Schönberggasse 1, 8001 Zurich, Switzerland. Phone: +41–44– 634–61–26. E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: christian.decker{at}econ.uzh.ch
Marco Ottaviani
§Department of Economics and IGIER, Bocconi University, Via Roberto Sarfatti 25, 20136 Milan, Italy. Phone: +39–02–5836–3385. E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marco Ottaviani
  • For correspondence: marco.ottaviani{at}unibocconi.it marco.ottaviani{at}unibocconi.it
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Data Availability

The study is based on publicly available data.

https://clinicaltrials.gov

Back to top
PreviousNext
Posted November 25, 2019.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Why so many significant phase III results in clinical trials?
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Why so many significant phase III results in clinical trials?
Jérôme Adda, Christian Decker, Marco Ottaviani
medRxiv 19001495; doi: https://doi.org/10.1101/19001495
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Why so many significant phase III results in clinical trials?
Jérôme Adda, Christian Decker, Marco Ottaviani
medRxiv 19001495; doi: https://doi.org/10.1101/19001495

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Economics
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)